William J. Steinbach

Federal Grant PI High Impact

Chair and Associate Dean

UAMS

Also affiliated: Goethe University Frankfurt (2012–2017); University of Bern (2017); Leeds General Infirmary (2012); Arkansas Children's Hospital (2022); Nationwide Children's Hospital (2008–2012); Lucile Packard Children's Hospital (2000–2001); Children's Hospital of Philadelphia (2015–2017); University of Massachusetts Chan Medical School (2006); Duke University (2002–2025); Baylor College of Medicine (2012); University of Toronto (2008); Great Ormond Street Hospital (2012); University Hospital of Bern (2017); Hospital for Sick Children (2012–2017); London South Bank University (2012); University of Iowa Stead Family Children’s Hospital (2012); Duke Medical Center (2002–2025); Stanford Medicine (2001–2003); Texas Children's Hospital (2012); Duke University Hospital (2017); Arkansas Children's Research Institute (2022–2026); University of York (2012–2015); The Ohio State University (2008–2012); Stanford University (2000–2003); McMaster University (2015)

Pediatrics, College of Medicine

68 h-index 287 pubs 27,716 cited

Research Areas

Biomedical Subjects

Links

ORCID Research Group UAMS TRI Profile

OverviewAI-generated summary

William J. Steinbach's research program focuses on the pathogenesis, diagnosis, and treatment of invasive fungal infections, particularly in immunosuppressed children. For over two decades, he has led an NIH-funded multidisciplinary clinical care and research program supporting this patient population. His work encompasses molecular, translational, and clinical investigations, with broader applications to all infections in immunocompromised patients.

Steinbach has significant experience as a principal investigator on federal grants, having led multiple R01 awards and T32 awards in molecular mycology and pediatric infectious diseases. He has also served on national scientific and research advisory panels. His scholarship is reflected in a high h-index of 68, over 280 publications, and more than 26,000 citations. He currently holds the Robert H. Fiser, Jr. MD Endowed Chair in Pediatrics and serves as Chair of Pediatrics and Associate Dean for Child Health at the University of Arkansas for Medical Sciences, in addition to being Pediatrician-in-Chief at Arkansas Children’s.

Metrics

h-index: 68
Publications: 287
Citations: 27,716

Positions

Chair and Associate Dean 2022–present

University of Arkansas for Medical Sciences Pediatrics, College of Medicine Institutional directory
Pediatrician-in-Chief 2022–present

Arkansas Children's Hospital ORCID

Selected Publications

Drugs for Parasitic Infections (2025)

2 citations DOI OpenAlex
New Approaches and a Call to Action (2025)

DOI OpenAlex
Structure-guided design and synthesis of C22- and C32-modified FK520 analogs with enhanced activity against human pathogenic fungi (2024)

1 citation DOI OpenAlex
Transition to Enteral Triazole Antifungal Therapy for Pediatric Invasive Candidiasis: Secondary Analysis of a Multicenter Cohort Study Conducted by the Pediatric Fungal Network (2024)

Journal of the Pediatric Infectious Diseases Society 3 citations DOI OpenAlex
Structure-guided design and synthesis of C22- and C32-modified FK520 analogs with enhanced activity against human pathogenic fungi (2024)

DOI OpenAlex
Fecal Microbiota Transplantation: Information for the Pediatrician (2023)

PEDIATRICS 24 citations DOI OpenAlex
Tuning sterol extraction kinetics yields a renal-sparing polyene antifungal (2023)

Nature 102 citations DOI OpenAlex
Enhanced fungal specificity and in vivo therapeutic efficacy of a C-22-modified FK520 analog against C. neoformans (2023)

mBio 6 citations DOI OpenAlex
Adjunctive Diagnostic Studies Completed Following Detection of Candidemia in Children: Secondary Analysis of Observed Practice From a Multicenter Cohort Study Conducted by the Pediatric Fungal Network (2023)

Journal of the Pediatric Infectious Diseases Society 6 citations DOI OpenAlex
Enhanced fungal specificity and in vivo therapeutic efficacy of a C-22 modified FK520 analog against C. neoformans (2023)

DOI OpenAlex
American Society for Transplantation and Cellular Therapy Series, #6: Management of Invasive Candidiasis in Hematopoietic Cell Transplantation Recipients (2023)

Transplantation and Cellular Therapy 4 citations DOI OpenAlex
Calcineurin Inhibitor CN585 Exhibits Off-Target Effects in the Human Fungal Pathogen Aspergillus fumigatus (2022)

1 citation DOI OpenAlex
Prospective Evaluation of the Fungitell® (1→3) <scp>Beta‐D‐Glucan</scp> Assay as a Diagnostic Tool for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplantation: A Report from the Children's Oncology Group (2022)

Pediatric Transplantation 10 citations DOI OpenAlex